Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Renal dysfunction reduces the diagnostic and prognostic value of serum CC16 for acute respiratory distress syndrome in intensive care patients

Fig. 2

Five ROC curves for the value of serum CC16 in diagnosing ARDS in critical care patients: ROC.1 shows the ability of serum CC16 to distinguish patients in the ARDS group vs. the control group; ROC.2 shows the ability of serum CC16 to distinguish patients in the ARDS group, ARDS+AKD group, and ARDS+CKD group vs. the control group; ROC.3 shows the ability of serum CC16 to distinguish patients in the ARDS group vs. the AKI group and CKD group; ROC.4 shows the ability of serum CC16 to distinguish patients in the ARDS group, ARDS+AKD group, and ARDS+CKD group vs. the AKI group and CKD group; and ROC.5 shows the ability of serum CC16 to distinguish patients among all groups

Back to article page